CELL THERAPY AND TECH S A DE C V has a total of 52 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are TRITECH BIOPHARMACEUTICALS CO LTD, HERMANN HOLGER LARS and IROKO CARDIO LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Mexico | 4 | |
#5 | Brazil | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 | |
#7 | Argentina | 2 | |
#8 | Canada | 2 | |
#9 | Chile | 2 | |
#10 | China | 2 | |
#11 | Ecuador | 2 | |
#12 | Israel | 2 | |
#13 | Philippines | 2 | |
#14 | Uruguay | 2 | |
#15 | Colombia | 1 | |
#16 | Hungary | 1 | |
#17 | Jordan | 1 | |
#18 | Republic of Korea | 1 | |
#19 | Morocco | 1 | |
#20 | Peru | 1 | |
#21 | Singapore | 1 | |
#22 | Ukraine | 1 | |
#23 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Magaña Castro José Agustín Rogelio | 19 |
#2 | Armendáriz Borunda Juan Socorro | 19 |
#3 | Armendariz Borunda Juan Socorro | 12 |
#4 | Magana Castro Jose Agustin Rogelio | 9 |
#5 | José Agustín Rogelio Magaña Castro | 8 |
#6 | Juan Socorro Armendáriz Borunda | 7 |
#7 | Cervantes Guadarrama Jorge | 7 |
#8 | Vázquez Cervantes Laura | 7 |
#9 | Hernández Aldana Nadiel | 7 |
#10 | Hernandez Aldana Nadiel | 7 |
Publication | Filing date | Title |
---|---|---|
MX368750B | Oil based semisolid pharmaceutical compositions containing pirfenidone for application in tissue repair. | |
MX2017010486A | A semi-solid topical composition containing an antimicrobial agent and pirfenidone for the treatment of chronic skin damage. | |
MX2016014775A | Pharmaceutical use of an extended-release composition containing pirfenidone for the treatment and reversal of human steatohepatitis (nafld/nash). | |
MX2012003694A | Semi-solid topical composition which contains pirfenidone and modified diallyl disulphide oxide (m-ddo) for eliminating or preventing acne. |